“…X-linked inhibitor of apoptosis is thought to act as a key determinant of apoptosis resistance by effectively inhibiting the activation of caspase-3, -7 and -9 (Deveraux et al, 1999;Holcik et al, 2001;Srinivasula et al, 2001;Suzuki et al, 2001). Thus, high expression of XIAP has been reported in many malignant tumour types, such as carcinomas of the breast, ovaries, lung, pancreas, cervix and prostate (Ferreira et al, 2001a, b;Liu et al, 2001;Gerhard et al, 2002;Hofmann et al, 2002;Mc Eleny et al, 2002;Parton et al, 2002;Sui et al, 2002) as well as leukaemias (Tamm et al, 2000). Moreover, upregulation of XIAP expression has been found to result in apoptosis resistance after exposure to anticancer drugs and ionising radiation (Li et al, 2000;Asselin et al, 2001;Holcik et al, 2001;Matsumiya et al, 2001), whereas downregulation of XIAP by antisense vectors increased the apoptosis sensitivity of carcinoma cell lines Holcik et al, 2001).…”